Cell signalling pathway involved in PACAP-induced AR4-2J cell proliferation

Area of Science:

• Molecular Biology
• Cell Signaling
• Cancer Research

Background:

• The neuropeptide pituitary adenylate activating peptide (PACAP) is known to promote pancreatic acinar tumor AR4-2J cell growth.
• This growth effect is independent of adenylate cyclase activation but is sensitive to pertussis toxin and SMS 201-995.
• The precise cell signaling pathways mediating PACAP's growth-promoting effects require elucidation.

Purpose of the Study:

• To investigate the cell signaling pathways involved in PACAP-induced AR4-2J cell proliferation.
• To determine the role of tyrosine kinase and phospholipase D (PLD) in PACAP's mitogenic effects.

Main Methods:

• AR4-2J cells were cultured and treated with PACAP-38 or PACAP-27.
• Tyrosine kinase and PLD activities were measured following PACAP stimulation.
• The effects of inhibitors (genistein, wortmannin, SMS 201-995, pertussis toxin) on PACAP-induced cell growth and enzyme activity were assessed.

Main Results:

• PACAP-38 and PACAP-27 dose-dependently activated both tyrosine kinase and PLD, an effect blocked by PACAP 7-38.
• SMS 201-995, genistein, and pertussis toxin inhibited PACAP-stimulated tyrosine kinase and PLD activation.
• PACAP-induced AR4-2J cell growth was significantly inhibited by genistein (tyrosine kinase inhibitor) and wortmannin (phosphatidylinositol 3-kinase inhibitor).

Conclusions:

• PACAP induces the concomitant activation of tyrosine kinase and PLD in AR4-2J cells.
• Inhibition of tyrosine kinase and PLD effectively blocks PACAP-induced AR4-2J cell proliferation.
• These findings strongly implicate tyrosine kinase and PLD as key mediators in PACAP-driven cell growth.